RankingsPricing
  1. US-listed companies
  2. NEUROONE MEDICAL TECHNOLOGIES Corp
  3. Raw

NEUROONE MEDICAL TECHNOLOGIES CorpNMTC

Market cap
$35.8M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Sep 30,
2019		Sep 30,
2020		Sep 30,
2021		Sep 30,
2022		Sep 30,
2023		Sep 30,
2024
Cash and cash equivalents----260,74947851
Accounts receivable------48,33633,237-176,636
Total------98,287704,53823
Deferred offering costs---------142,633
Prepaid expenses---------216,461
Total current assets13,8512051,838-301,751471275
Net Intangibles, beginning----178,838156,523134,207111,89289,57767,262
Right-of-use asset-----282,211288,948181,355169,059254,910
Property and equipment, net----52,026166,031223,329353,599525,753416,843
Total assets13,8512051,8384,277532,615581385
Accounts payable-9,96616,65922,3621762,538528,829927,662685,1041
Total-3,000--617,721512,762644,249715,83911
Total current liabilities4,62835,59483,330117,927221322
Balance as of beginning of year---------2
Operating lease liability, long term-----254,328202,895119,55655,284194,392
Total liabilities17,12835,59483,330117,927231325
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding.----------
Common stock, $0.001 par value; 100,000,000 shares authorized; 30,816,499 and 23,928,945 shares issued and outstanding as of September 30, 2024 and 2023, respectively.5,0735,0735,0735,07313,49422,18135,83416,21723,92930,816
Additional paid–in capital28,07776,72393,48345,577163347606976
Accumulated deficit---180,048-227,823-17,238,871-30,879,031-40,827,199-50,826,812-62,686,303-75
Total stockholders’ equity-3,277-35,389-81,492-113,650-1,237,57827106822,013
Total liabilities and stockholders’ equity13,8512051,8384,277532,615581385